Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo Rispens

Showing results (111-120 of 304) with videos related to

Pageof 31
Sort By:
Frontiers in Immunology|September 25, 2020
MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc <i>N</i>-GlycosylationThomas Sénard, Andrea F G Gargano, David Falck, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 19, 2021
Fc Galactosylation Promotes Hexamerization of Human IgG1, Leading to Enhanced Classical Complement ActivationThijs L J van Osch, Jan Nouta, Ninotska I L Derksen, et al.
The Journal of Rheumatology|January 17, 2017
Prevalence of Anti-infliximab Antibodies and Their Associated Co-factors in Children with Refractory Arthritis and/or Uveitis: A Retrospective Longitudinal Cohort StudyFlorence A Aeschlimann, Felix Angst, Kevin D Hofer, et al.
Clinical and Translational Gastroenterology|April 30, 2019
Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and PancreatitisTamsin Cargill, Mateusz Makuch, Ross Sadler, et al.
Therapeutic Drug Monitoring|August 30, 2019
Monitoring of Adalimumab Concentrations at Home in Patients with Inflammatory Bowel Disease Using Dried Blood SamplesSophie E Berends, Karien Bloem, Annick de Vries, et al.
Clinical and Translational Gastroenterology|July 18, 2019
Correction: Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and PancreatitisTamsin Cargill, Mateusz Makuch, Ross Sadler, et al.
The Journal of Allergy and Clinical Immunology|October 1, 2013
Phenotypic differences between IgG4+ and IgG1+ B cells point to distinct regulation of the IgG4 responseLaura C Lighaam, Ellen Vermeulen, Tamara den Bleker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2021
Natalizumab concentrations during pregnancy in three patients with multiple sclerosisAlyssa A Toorop, Theo Rispens, Eva Mm Strijbis, et al.
Analytical and Bioanalytical Chemistry|July 10, 2013
A rapid assay for on-site monitoring of infliximab trough levels: a feasibility studyPaul L A M Corstjens, Herma H Fidder, Karien C Wiesmeijer, et al.
Neurology|September 26, 2019
The natalizumab wearing-off effect: End of natalizumab cycle, recurrence of MS symptomsZoé L E van Kempen, Djoeke Doesburg, Iris Dekker, et al.
Pageof 31

Showing results (111-120 of 304) with videos related to

Sort By:
Pageof 31
Frontiers in Immunology|September 25, 2020
MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc <i>N</i>-GlycosylationThomas Sénard, Andrea F G Gargano, David Falck, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 19, 2021
Fc Galactosylation Promotes Hexamerization of Human IgG1, Leading to Enhanced Classical Complement ActivationThijs L J van Osch, Jan Nouta, Ninotska I L Derksen, et al.
The Journal of Rheumatology|January 17, 2017
Prevalence of Anti-infliximab Antibodies and Their Associated Co-factors in Children with Refractory Arthritis and/or Uveitis: A Retrospective Longitudinal Cohort StudyFlorence A Aeschlimann, Felix Angst, Kevin D Hofer, et al.
Clinical and Translational Gastroenterology|April 30, 2019
Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and PancreatitisTamsin Cargill, Mateusz Makuch, Ross Sadler, et al.
Therapeutic Drug Monitoring|August 30, 2019
Monitoring of Adalimumab Concentrations at Home in Patients with Inflammatory Bowel Disease Using Dried Blood SamplesSophie E Berends, Karien Bloem, Annick de Vries, et al.
Clinical and Translational Gastroenterology|July 18, 2019
Correction: Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and PancreatitisTamsin Cargill, Mateusz Makuch, Ross Sadler, et al.
The Journal of Allergy and Clinical Immunology|October 1, 2013
Phenotypic differences between IgG4+ and IgG1+ B cells point to distinct regulation of the IgG4 responseLaura C Lighaam, Ellen Vermeulen, Tamara den Bleker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2021
Natalizumab concentrations during pregnancy in three patients with multiple sclerosisAlyssa A Toorop, Theo Rispens, Eva Mm Strijbis, et al.
Analytical and Bioanalytical Chemistry|July 10, 2013
A rapid assay for on-site monitoring of infliximab trough levels: a feasibility studyPaul L A M Corstjens, Herma H Fidder, Karien C Wiesmeijer, et al.
Neurology|September 26, 2019
The natalizumab wearing-off effect: End of natalizumab cycle, recurrence of MS symptomsZoé L E van Kempen, Djoeke Doesburg, Iris Dekker, et al.
Pageof 31